Literature DB >> 10223343

Protection of baculovirus-vectors against complement-mediated inactivation by recombinant soluble complement receptor type 1.

C Hofmann1, A Hüser, W Lehnert, M Strauss.   

Abstract

Baculovirus-based vectors are efficient means for gene transfer into hepatocytes in vitro. However, gene transfer in vivo is hampered by inactivation of baculovirus by the complement system. In this study, we demonstrate protection of baculovirus vectors against complement-mediated inactivation through recombinant soluble complement receptor type 1 (sCR1). Blocking of only the alternative complement pathway by a mutant of sCR1 did not result in baculovirus survival in human serum. The data suggest the use of sCR1 as a potent drug to facilitate baculovirus-mediated gene transfer into hepatocytes in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10223343     DOI: 10.1515/BC.1999.052

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  11 in total

Review 1.  Biological gene delivery vehicles: beyond viral vectors.

Authors:  Yiqi Seow; Matthew J Wood
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

Review 2.  Baculovirus: an insect-derived vector for diverse gene transfer applications.

Authors:  Kari J Airenne; Yu-Chen Hu; Thomas A Kost; Richard H Smith; Robert M Kotin; Chikako Ono; Yoshiharu Matsuura; Shu Wang; Seppo Ylä-Herttuala
Journal:  Mol Ther       Date:  2013-02-26       Impact factor: 11.454

3.  Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides.

Authors:  Anna R Mäkelä; Heli Matilainen; Daniel J White; Erkki Ruoslahti; Christian Oker-Blom
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Gene transfer mediated by recombinant baculovirus into mouse eye.

Authors:  F Haeseleer; Y Imanishi; D A Saperstein; K Palczewski
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-12       Impact factor: 4.799

5.  A GP64-null baculovirus pseudotyped with vesicular stomatitis virus G protein.

Authors:  J T Mangor; S A Monsma; M C Johnson; G W Blissard
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Preclinical evaluation of innate immunity to baculovirus gene therapy vectors in whole human blood.

Authors:  Lindsay J Georgopoulos; Graciela Elgue; Javier Sanchez; Vincent Dussupt; Paola Magotti; John D Lambris; Thomas H Tötterman; Norman J Maitland; Bo Nilsson
Journal:  Mol Immunol       Date:  2009-08-08       Impact factor: 4.407

7.  Screening of complement inhibitors: shielded baculoviruses increase the safety and efficacy of gene delivery.

Authors:  Minna U Kaikkonen; Antti I Maatta; Seppo Ylä-Herttuala; Kari J Airenne
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

Review 8.  Baculovirus as versatile vectors for protein expression in insect and mammalian cells.

Authors:  Thomas A Kost; J Patrick Condreay; Donald L Jarvis
Journal:  Nat Biotechnol       Date:  2005-05       Impact factor: 54.908

9.  Local Immune Stimulation by Intravesical Instillation of Baculovirus to Enable Bladder Cancer Therapy.

Authors:  Wei Xia Ang; Ying Zhao; Timothy Kwang; Chunxiao Wu; Can Chen; Han Chong Toh; Ratha Mahendran; Kesavan Esuvaranathan; Shu Wang
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

10.  Baculoviruses as Vectors for Gene Therapy against Human Prostate Cancer.

Authors:  Lindsay J. Stanbridge; Vincent Dussupt; Norman J. Maitland
Journal:  J Biomed Biotechnol       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.